Lamivudine(LAM) Good Responder Study
NCT01128686 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2016-09-13
Summary
This is to evaluate the proportion of subjects who show good responses to LAM treatment in Korea.
Conditions
- Hepatitis B, Chronic
Interventions
- OTHER
-
No intervention
This study is retrospective chart review
Sponsors & Collaborators
- collaborator INDUSTRY
-
ViiV Healthcare
lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · ViiV Healthcare
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-08-31
- Primary Completion
- 2011-06-30
- Completion
- 2011-06-30
Countries
- South Korea
More Related Trials
-
Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)
NCT00140725 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients
NCT00798460 ·Status: TERMINATED ·Phase: PHASE4
-
A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B Alone
NCT00354653 ·Status: COMPLETED ·Phase: PHASE4
-
Compare Continuing Lamivudine Plus Adefovir or Adefovir Versus Switching to Entecavir Plus Adefovir in Patients With LAM-resistant Chronic Hepatitis B
NCT02482272 ·Status: UNKNOWN ·Phase: PHASE4
-
Tenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Lamivudine Plus Adefovir
NCT03236584 ·Status: UNKNOWN ·Phase: PHASE3
-
Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B
NCT00531167 ·Status: COMPLETED ·Phase: PHASE4
-
Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis B
NCT01270165 ·Status: UNKNOWN ·Phase: PHASE3
-
Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA
NCT00625560 ·Status: COMPLETED ·Phase: PHASE4
-
Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNA
NCT00625339 ·Status: COMPLETED ·Phase: PHASE4
-
A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection
NCT00393484 ·Status: COMPLETED ·Phase: PHASE4
-
A Korean Cohort Study of TDF Rescue Therapy for Difficult-to-treat CHB Patients: a Comparison Between TDF Monotherapy and TDF-based Combination Therapy
NCT02019966 ·Status: COMPLETED
-
Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2)
NCT00120796 ·Status: TERMINATED ·Phase: PHASE3
-
Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine
NCT01580202 ·Status: COMPLETED ·Phase: PHASE3
-
Entecavir Plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Patients Who Fail Lamivudine Plus Adefovir
NCT01023217 ·Status: COMPLETED ·Phase: PHASE4
-
Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection
NCT00362635 ·Status: COMPLETED ·Phase: PHASE3
-
Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients
NCT00558493 ·Status: COMPLETED ·Phase: PHASE4
-
Long-Term Lamivudine Therapy for Chronic Hepatitis B
NCT00120354 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot Study
NCT01804387 ·Status: UNKNOWN ·Phase: PHASE4
-
Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNA
NCT00637663 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine
NCT04289987 ·Status: COMPLETED ·Phase: PHASE2
-
Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients
NCT00823550 ·Status: UNKNOWN ·Phase: PHASE4
-
Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load
NCT01013272 ·Status: COMPLETED ·Phase: NA
-
Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients
NCT01491295 ·Status: UNKNOWN ·Phase: PHASE4
-
A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B
NCT00057265 ·Status: COMPLETED ·Phase: PHASE3
-
Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination Therapy
NCT01595633 ·Status: UNKNOWN ·Phase: PHASE4